These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 9157576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [Abstract] [Full Text] [Related]

  • 4. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S, Klinke S, von Depka Prondzinski M, Kreuz W, Ganser A, Scharrer I.
    Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):783-7. PubMed ID: 10414227
    [Abstract] [Full Text] [Related]

  • 5. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct 25; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 6. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1995 Jul 25; 74(1):139-48. PubMed ID: 8578447
    [Abstract] [Full Text] [Related]

  • 7. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B, He X, Dahlbäck B.
    Thromb Haemost; 1995 May 25; 73(5):743-5. PubMed ID: 7482396
    [Abstract] [Full Text] [Related]

  • 8. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V, Leone G.
    Haematologica; 1995 May 25; 80(4):344-56. PubMed ID: 7590506
    [Abstract] [Full Text] [Related]

  • 9. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.
    Thromb Haemost; 2000 Apr 25; 83(4):577-82. PubMed ID: 10780320
    [Abstract] [Full Text] [Related]

  • 10. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP, van Rumpt D, Hamulyák K, Reitsma PH, Bertina RM.
    Thromb Haemost; 1995 Aug 25; 74(2):580-3. PubMed ID: 8584987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
    Pereira J, Quiroga T, Goycoolea M, Muñoz B, Hidalgo P, Kaltwasser G, Mezzano D.
    Rev Med Chil; 1996 Jun 25; 124(6):663-8. PubMed ID: 9041721
    [Abstract] [Full Text] [Related]

  • 13. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH.
    Nature; 1994 May 05; 369(6475):64-7. PubMed ID: 8164741
    [Abstract] [Full Text] [Related]

  • 14. Factor V Leiden mutation in one family of Chinese origin.
    Wu J, Gu J, Xu J, Wang J, Sun Z, Smirnov MD, Morrissey JH, Esmon N.
    Chin Med J (Engl); 2001 Apr 05; 114(4):379-81. PubMed ID: 11780458
    [Abstract] [Full Text] [Related]

  • 15. A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population.
    Castoldi E, Lunghi B, Mingozzi F, Muleo G, Redaelli R, Mariani G, Bernardi F.
    Haematologica; 2001 Jun 05; 86(6):629-33. PubMed ID: 11418372
    [Abstract] [Full Text] [Related]

  • 16. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M.
    Thromb Haemost; 1999 Feb 05; 81(2):193-7. PubMed ID: 10063990
    [Abstract] [Full Text] [Related]

  • 17. [Severe hereditary coagulation factor V deficiency caused by two novel heterozygous mutations].
    Zhou RF, Fu QH, Xu XC, Wang WB, Wu WM, Ding QL, Xie S, Zhai ZM, Hu YQ, Wang XF, Wu JS, Wang HL.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar 05; 26(3):129-32. PubMed ID: 15946520
    [Abstract] [Full Text] [Related]

  • 18. Phenotyping and genotyping of coagulation factor V Leiden.
    Engel H, Zwang L, van Vliet HH, Michiels JJ, Stibbe J, Lindemans J.
    Thromb Haemost; 1996 Feb 05; 75(2):267-9. PubMed ID: 8815574
    [Abstract] [Full Text] [Related]

  • 19. Activated protein C resistance: molecular mechanisms.
    Griffin JH, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS.
    Thromb Haemost; 1995 Jul 05; 74(1):444-8. PubMed ID: 8578503
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G, Valverde S.
    Blood Coagul Fibrinolysis; 2007 Oct 05; 18(7):603-10. PubMed ID: 17890946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.